E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/21/2006 in the Prospect News Biotech Daily.

JMP keeps Stryker at market perform

Stryker Corp. was maintained at market perform by JMP Securities analyst Robert C. Faulkner on news of uncertainty surrounding the launch of OP-1. The analyst, in his estimates, pushed back the launch from the third-quarter 2007 to the first-quarter 2008, resulting in a $23 million impact in 2007, an $85 million impact in 2008, a $20 million impact in 2009 and an impact of $16 million in 2010. Shares of the Kalamazoo, Mich.-based orthopedics product company were up 93 cents, or 2.15%, at $44.13 on volume of 3,212,500 shares versus the three-month running average of 1,603,770 shares. (NYSE: SYK)


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.